Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AudioStocks, Inc. was a financial communications and digital media company that provided a proprietary software platform for the distribution of audio-based corporate content and investor relations materials. The company's services included facilitating executive participation in industry roundtables, appending rich media to press releases, and providing interview-based audio for financial research. While it functioned as a media and technology service provider, it was deeply embedded in the life sciences community, frequently broadcasting developments from biotechnology and medical technology firms. In May 2009, AudioStocks rebranded as Shrink Nanotechnologies, Inc., shifting its focus toward nano-scale manufacturing and biotechnology applications such as lab-on-a-chip diagnostics. The company was founded by Mark L. Baum, a notable entrepreneur who later founded Harrow Health and other healthcare ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AudioStocks.